img

Global Next Generation Sequencing (NGS) Market Research Report 2024


Published on: 2024-01-04 | No of Pages : 400 | Industry : Medical

Publisher : MRA | Format : PDF

Global Next Generation Sequencing (NGS) Market Research Report 2024

Next Generation Sequencing (NGS) is a high-throughput method for rapid sequencing of base pairs of DNA or RNA samples.
According to MRAResearch’s new survey, global Next Generation Sequencing (NGS) market is projected to reach US$ 4686.3 million in 2033, increasing from US$ 3690.2 million in 2022, with the CAGR of 3.4% during the period of 2023 to 2033. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Next Generation Sequencing (NGS) market research.
The classification of Next-Generation Sequencing (NGS) Services includes Targeted Sequencing, Whole Exome Sequencing and Whole Genome Sequencing, and the proportion of Targeted Sequencing in 2019 is about 55%.
Next-Generation Sequencing (NGS) Services is widely used in Hospitals and Clinics, Biopharma Companies, Academic & Research Organizations and Other. The most proportion of Next-Generation Sequencing (NGS) Services is Hospitals and Clinics, and the proportion in 2019 is about 56%.
North America is the largest consumption place, with a consumption market share nearly 37% in 2019. Following North America, Europe is the second largest consumption place with the consumption market share of about 32%.
Eurofins Scientific, Natera, BGI, Illumina, etc. are the leaders of the industry.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2033), aims to help readers to get a comprehensive understanding of global Next Generation Sequencing (NGS) market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.



By Company


Illumina
Thermo Fisher Scientific
Pacific Biosciences of California
Beijing Genomics Institute
Qiagen
Roche
Agilent Technologies
Perkinelmer
Genomatix
PierianDx
Eurofins Scientific
Gatc Biotech
Oxford Nanopore Technologies
Bio-Rad Laboratories
DNASTAR
Biomatters
Partek
New England Biolabs
Myriad Genetics
Macrogen
Segment by Type
Targeted Sequencing
Whole Exome Sequencing
Whole Genome Sequencing

Segment by Application


Academic & Government Research Institutes
Pharmaceutical Companies
Biotechnology Companies
Hospitals & Clinics
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
The Next Generation Sequencing (NGS) report covers below items
Chapter 1Product Basic Information (Definition, Type and Application)
Chapter 2Global market size, regional market size. Market Opportunities and Challenges
Chapter 3Companies’ Competition Patterns
Chapter 4Product Type Analysis
Chapter 5Product Application Analysis
Chapter 6 to 10Country Level Value Analysis
Chapter 11Companies' Outline
Chapter 12Market Conclusions
Chapter 13Research Methodology and Data Source

Table of Content

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Next Generation Sequencing (NGS) Market Size Growth Rate by Type: 2018 VS 2022 VS 2033
1.2.2 Targeted Sequencing
1.2.3 Whole Exome Sequencing
1.2.4 Whole Genome Sequencing
1.3 Market by Application
1.3.1 Global Next Generation Sequencing (NGS) Market Growth by Application: 2018 VS 2022 VS 2033
1.3.2 Academic & Government Research Institutes
1.3.3 Pharmaceutical Companies
1.3.4 Biotechnology Companies
1.3.5 Hospitals & Clinics
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Next Generation Sequencing (NGS) Market Perspective (2018-2033)
2.2 Next Generation Sequencing (NGS) Growth Trends by Region
2.2.1 Global Next Generation Sequencing (NGS) Market Size by Region: 2018 VS 2022 VS 2033
2.2.2 Next Generation Sequencing (NGS) Historic Market Size by Region (2018-2023)
2.2.3 Next Generation Sequencing (NGS) Forecasted Market Size by Region (2024-2033)
2.3 Next Generation Sequencing (NGS) Market Dynamics
2.3.1 Next Generation Sequencing (NGS) Industry Trends
2.3.2 Next Generation Sequencing (NGS) Market Drivers
2.3.3 Next Generation Sequencing (NGS) Market Challenges
2.3.4 Next Generation Sequencing (NGS) Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Next Generation Sequencing (NGS) Players by Revenue
3.1.1 Global Top Next Generation Sequencing (NGS) Players by Revenue (2018-2023)
3.1.2 Global Next Generation Sequencing (NGS) Revenue Market Share by Players (2018-2023)
3.2 Global Next Generation Sequencing (NGS) Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Next Generation Sequencing (NGS) Revenue
3.4 Global Next Generation Sequencing (NGS) Market Concentration Ratio
3.4.1 Global Next Generation Sequencing (NGS) Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Next Generation Sequencing (NGS) Revenue in 2022
3.5 Next Generation Sequencing (NGS) Key Players Head office and Area Served
3.6 Key Players Next Generation Sequencing (NGS) Product Solution and Service
3.7 Date of Enter into Next Generation Sequencing (NGS) Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Next Generation Sequencing (NGS) Breakdown Data by Type
4.1 Global Next Generation Sequencing (NGS) Historic Market Size by Type (2018-2023)
4.2 Global Next Generation Sequencing (NGS) Forecasted Market Size by Type (2024-2033)
5 Next Generation Sequencing (NGS) Breakdown Data by Application
5.1 Global Next Generation Sequencing (NGS) Historic Market Size by Application (2018-2023)
5.2 Global Next Generation Sequencing (NGS) Forecasted Market Size by Application (2024-2033)
6 North America
6.1 North America Next Generation Sequencing (NGS) Market Size (2018-2033)
6.2 North America Next Generation Sequencing (NGS) Market Growth Rate by Country: 2018 VS 2022 VS 2033
6.3 North America Next Generation Sequencing (NGS) Market Size by Country (2018-2023)
6.4 North America Next Generation Sequencing (NGS) Market Size by Country (2024-2033)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Next Generation Sequencing (NGS) Market Size (2018-2033)
7.2 Europe Next Generation Sequencing (NGS) Market Growth Rate by Country: 2018 VS 2022 VS 2033
7.3 Europe Next Generation Sequencing (NGS) Market Size by Country (2018-2023)
7.4 Europe Next Generation Sequencing (NGS) Market Size by Country (2024-2033)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Next Generation Sequencing (NGS) Market Size (2018-2033)
8.2 Asia-Pacific Next Generation Sequencing (NGS) Market Growth Rate by Region: 2018 VS 2022 VS 2033
8.3 Asia-Pacific Next Generation Sequencing (NGS) Market Size by Region (2018-2023)
8.4 Asia-Pacific Next Generation Sequencing (NGS) Market Size by Region (2024-2033)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Next Generation Sequencing (NGS) Market Size (2018-2033)
9.2 Latin America Next Generation Sequencing (NGS) Market Growth Rate by Country: 2018 VS 2022 VS 2033
9.3 Latin America Next Generation Sequencing (NGS) Market Size by Country (2018-2023)
9.4 Latin America Next Generation Sequencing (NGS) Market Size by Country (2024-2033)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Next Generation Sequencing (NGS) Market Size (2018-2033)
10.2 Middle East & Africa Next Generation Sequencing (NGS) Market Growth Rate by Country: 2018 VS 2022 VS 2033
10.3 Middle East & Africa Next Generation Sequencing (NGS) Market Size by Country (2018-2023)
10.4 Middle East & Africa Next Generation Sequencing (NGS) Market Size by Country (2024-2033)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Illumina
11.1.1 Illumina Company Detail
11.1.2 Illumina Business Overview
11.1.3 Illumina Next Generation Sequencing (NGS) Introduction
11.1.4 Illumina Revenue in Next Generation Sequencing (NGS) Business (2018-2023)
11.1.5 Illumina Recent Development
11.2 Thermo Fisher Scientific
11.2.1 Thermo Fisher Scientific Company Detail
11.2.2 Thermo Fisher Scientific Business Overview
11.2.3 Thermo Fisher Scientific Next Generation Sequencing (NGS) Introduction
11.2.4 Thermo Fisher Scientific Revenue in Next Generation Sequencing (NGS) Business (2018-2023)
11.2.5 Thermo Fisher Scientific Recent Development
11.3 Pacific Biosciences of California
11.3.1 Pacific Biosciences of California Company Detail
11.3.2 Pacific Biosciences of California Business Overview
11.3.3 Pacific Biosciences of California Next Generation Sequencing (NGS) Introduction
11.3.4 Pacific Biosciences of California Revenue in Next Generation Sequencing (NGS) Business (2018-2023)
11.3.5 Pacific Biosciences of California Recent Development
11.4 Beijing Genomics Institute
11.4.1 Beijing Genomics Institute Company Detail
11.4.2 Beijing Genomics Institute Business Overview
11.4.3 Beijing Genomics Institute Next Generation Sequencing (NGS) Introduction
11.4.4 Beijing Genomics Institute Revenue in Next Generation Sequencing (NGS) Business (2018-2023)
11.4.5 Beijing Genomics Institute Recent Development
11.5 Qiagen
11.5.1 Qiagen Company Detail
11.5.2 Qiagen Business Overview
11.5.3 Qiagen Next Generation Sequencing (NGS) Introduction
11.5.4 Qiagen Revenue in Next Generation Sequencing (NGS) Business (2018-2023)
11.5.5 Qiagen Recent Development
11.6 Roche
11.6.1 Roche Company Detail
11.6.2 Roche Business Overview
11.6.3 Roche Next Generation Sequencing (NGS) Introduction
11.6.4 Roche Revenue in Next Generation Sequencing (NGS) Business (2018-2023)
11.6.5 Roche Recent Development
11.7 Agilent Technologies
11.7.1 Agilent Technologies Company Detail
11.7.2 Agilent Technologies Business Overview
11.7.3 Agilent Technologies Next Generation Sequencing (NGS) Introduction
11.7.4 Agilent Technologies Revenue in Next Generation Sequencing (NGS) Business (2018-2023)
11.7.5 Agilent Technologies Recent Development
11.8 Perkinelmer
11.8.1 Perkinelmer Company Detail
11.8.2 Perkinelmer Business Overview
11.8.3 Perkinelmer Next Generation Sequencing (NGS) Introduction
11.8.4 Perkinelmer Revenue in Next Generation Sequencing (NGS) Business (2018-2023)
11.8.5 Perkinelmer Recent Development
11.9 Genomatix
11.9.1 Genomatix Company Detail
11.9.2 Genomatix Business Overview
11.9.3 Genomatix Next Generation Sequencing (NGS) Introduction
11.9.4 Genomatix Revenue in Next Generation Sequencing (NGS) Business (2018-2023)
11.9.5 Genomatix Recent Development
11.10 PierianDx
11.10.1 PierianDx Company Detail
11.10.2 PierianDx Business Overview
11.10.3 PierianDx Next Generation Sequencing (NGS) Introduction
11.10.4 PierianDx Revenue in Next Generation Sequencing (NGS) Business (2018-2023)
11.10.5 PierianDx Recent Development
11.11 Eurofins Scientific
11.11.1 Eurofins Scientific Company Detail
11.11.2 Eurofins Scientific Business Overview
11.11.3 Eurofins Scientific Next Generation Sequencing (NGS) Introduction
11.11.4 Eurofins Scientific Revenue in Next Generation Sequencing (NGS) Business (2018-2023)
11.11.5 Eurofins Scientific Recent Development
11.12 Gatc Biotech
11.12.1 Gatc Biotech Company Detail
11.12.2 Gatc Biotech Business Overview
11.12.3 Gatc Biotech Next Generation Sequencing (NGS) Introduction
11.12.4 Gatc Biotech Revenue in Next Generation Sequencing (NGS) Business (2018-2023)
11.12.5 Gatc Biotech Recent Development
11.13 Oxford Nanopore Technologies
11.13.1 Oxford Nanopore Technologies Company Detail
11.13.2 Oxford Nanopore Technologies Business Overview
11.13.3 Oxford Nanopore Technologies Next Generation Sequencing (NGS) Introduction
11.13.4 Oxford Nanopore Technologies Revenue in Next Generation Sequencing (NGS) Business (2018-2023)
11.13.5 Oxford Nanopore Technologies Recent Development
11.14 Bio-Rad Laboratories
11.14.1 Bio-Rad Laboratories Company Detail
11.14.2 Bio-Rad Laboratories Business Overview
11.14.3 Bio-Rad Laboratories Next Generation Sequencing (NGS) Introduction
11.14.4 Bio-Rad Laboratories Revenue in Next Generation Sequencing (NGS) Business (2018-2023)
11.14.5 Bio-Rad Laboratories Recent Development
11.15 DNASTAR
11.15.1 DNASTAR Company Detail
11.15.2 DNASTAR Business Overview
11.15.3 DNASTAR Next Generation Sequencing (NGS) Introduction
11.15.4 DNASTAR Revenue in Next Generation Sequencing (NGS) Business (2018-2023)
11.15.5 DNASTAR Recent Development
11.16 Biomatters
11.16.1 Biomatters Company Detail
11.16.2 Biomatters Business Overview
11.16.3 Biomatters Next Generation Sequencing (NGS) Introduction
11.16.4 Biomatters Revenue in Next Generation Sequencing (NGS) Business (2018-2023)
11.16.5 Biomatters Recent Development
11.17 Partek
11.17.1 Partek Company Detail
11.17.2 Partek Business Overview
11.17.3 Partek Next Generation Sequencing (NGS) Introduction
11.17.4 Partek Revenue in Next Generation Sequencing (NGS) Business (2018-2023)
11.17.5 Partek Recent Development
11.18 New England Biolabs
11.18.1 New England Biolabs Company Detail
11.18.2 New England Biolabs Business Overview
11.18.3 New England Biolabs Next Generation Sequencing (NGS) Introduction
11.18.4 New England Biolabs Revenue in Next Generation Sequencing (NGS) Business (2018-2023)
11.18.5 New England Biolabs Recent Development
11.19 Myriad Genetics
11.19.1 Myriad Genetics Company Detail
11.19.2 Myriad Genetics Business Overview
11.19.3 Myriad Genetics Next Generation Sequencing (NGS) Introduction
11.19.4 Myriad Genetics Revenue in Next Generation Sequencing (NGS) Business (2018-2023)
11.19.5 Myriad Genetics Recent Development
11.20 Macrogen
11.20.1 Macrogen Company Detail
11.20.2 Macrogen Business Overview
11.20.3 Macrogen Next Generation Sequencing (NGS) Introduction
11.20.4 Macrogen Revenue in Next Generation Sequencing (NGS) Business (2018-2023)
11.20.5 Macrogen Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Figure

List of Tables
Table 1. Global Next Generation Sequencing (NGS) Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2033
Table 2. Key Players of Targeted Sequencing
Table 3. Key Players of Whole Exome Sequencing
Table 4. Key Players of Whole Genome Sequencing
Table 5. Global Next Generation Sequencing (NGS) Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2033
Table 6. Global Next Generation Sequencing (NGS) Market Size by Region (US$ Million): 2018 VS 2022 VS 2033
Table 7. Global Next Generation Sequencing (NGS) Market Size by Region (2018-2023) & (US$ Million)
Table 8. Global Next Generation Sequencing (NGS) Market Share by Region (2018-2023)
Table 9. Global Next Generation Sequencing (NGS) Forecasted Market Size by Region (2024-2033) & (US$ Million)
Table 10. Global Next Generation Sequencing (NGS) Market Share by Region (2024-2033)
Table 11. Next Generation Sequencing (NGS) Market Trends
Table 12. Next Generation Sequencing (NGS) Market Drivers
Table 13. Next Generation Sequencing (NGS) Market Challenges
Table 14. Next Generation Sequencing (NGS) Market Restraints
Table 15. Global Next Generation Sequencing (NGS) Revenue by Players (2018-2023) & (US$ Million)
Table 16. Global Next Generation Sequencing (NGS) Market Share by Players (2018-2023)
Table 17. Global Top Next Generation Sequencing (NGS) Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Next Generation Sequencing (NGS) as of 2022)
Table 18. Ranking of Global Top Next Generation Sequencing (NGS) Companies by Revenue (US$ Million) in 2022
Table 19. Global 5 Largest Players Market Share by Next Generation Sequencing (NGS) Revenue (CR5 and HHI) & (2018-2023)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players Next Generation Sequencing (NGS) Product Solution and Service
Table 22. Date of Enter into Next Generation Sequencing (NGS) Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Next Generation Sequencing (NGS) Market Size by Type (2018-2023) & (US$ Million)
Table 25. Global Next Generation Sequencing (NGS) Revenue Market Share by Type (2018-2023)
Table 26. Global Next Generation Sequencing (NGS) Forecasted Market Size by Type (2024-2033) & (US$ Million)
Table 27. Global Next Generation Sequencing (NGS) Revenue Market Share by Type (2024-2033)
Table 28. Global Next Generation Sequencing (NGS) Market Size by Application (2018-2023) & (US$ Million)
Table 29. Global Next Generation Sequencing (NGS) Revenue Market Share by Application (2018-2023)
Table 30. Global Next Generation Sequencing (NGS) Forecasted Market Size by Application (2024-2033) & (US$ Million)
Table 31. Global Next Generation Sequencing (NGS) Revenue Market Share by Application (2024-2033)
Table 32. North America Next Generation Sequencing (NGS) Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 33. North America Next Generation Sequencing (NGS) Market Size by Country (2018-2023) & (US$ Million)
Table 34. North America Next Generation Sequencing (NGS) Market Size by Country (2024-2033) & (US$ Million)
Table 35. Europe Next Generation Sequencing (NGS) Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 36. Europe Next Generation Sequencing (NGS) Market Size by Country (2018-2023) & (US$ Million)
Table 37. Europe Next Generation Sequencing (NGS) Market Size by Country (2024-2033) & (US$ Million)
Table 38. Asia-Pacific Next Generation Sequencing (NGS) Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2033
Table 39. Asia-Pacific Next Generation Sequencing (NGS) Market Size by Region (2018-2023) & (US$ Million)
Table 40. Asia-Pacific Next Generation Sequencing (NGS) Market Size by Region (2024-2033) & (US$ Million)
Table 41. Latin America Next Generation Sequencing (NGS) Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 42. Latin America Next Generation Sequencing (NGS) Market Size by Country (2018-2023) & (US$ Million)
Table 43. Latin America Next Generation Sequencing (NGS) Market Size by Country (2024-2033) & (US$ Million)
Table 44. Middle East & Africa Next Generation Sequencing (NGS) Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 45. Middle East & Africa Next Generation Sequencing (NGS) Market Size by Country (2018-2023) & (US$ Million)
Table 46. Middle East & Africa Next Generation Sequencing (NGS) Market Size by Country (2024-2033) & (US$ Million)
Table 47. Illumina Company Detail
Table 48. Illumina Business Overview
Table 49. Illumina Next Generation Sequencing (NGS) Product
Table 50. Illumina Revenue in Next Generation Sequencing (NGS) Business (2018-2023) & (US$ Million)
Table 51. Illumina Recent Development
Table 52. Thermo Fisher Scientific Company Detail
Table 53. Thermo Fisher Scientific Business Overview
Table 54. Thermo Fisher Scientific Next Generation Sequencing (NGS) Product
Table 55. Thermo Fisher Scientific Revenue in Next Generation Sequencing (NGS) Business (2018-2023) & (US$ Million)
Table 56. Thermo Fisher Scientific Recent Development
Table 57. Pacific Biosciences of California Company Detail
Table 58. Pacific Biosciences of California Business Overview
Table 59. Pacific Biosciences of California Next Generation Sequencing (NGS) Product
Table 60. Pacific Biosciences of California Revenue in Next Generation Sequencing (NGS) Business (2018-2023) & (US$ Million)
Table 61. Pacific Biosciences of California Recent Development
Table 62. Beijing Genomics Institute Company Detail
Table 63. Beijing Genomics Institute Business Overview
Table 64. Beijing Genomics Institute Next Generation Sequencing (NGS) Product
Table 65. Beijing Genomics Institute Revenue in Next Generation Sequencing (NGS) Business (2018-2023) & (US$ Million)
Table 66. Beijing Genomics Institute Recent Development
Table 67. Qiagen Company Detail
Table 68. Qiagen Business Overview
Table 69. Qiagen Next Generation Sequencing (NGS) Product
Table 70. Qiagen Revenue in Next Generation Sequencing (NGS) Business (2018-2023) & (US$ Million)
Table 71. Qiagen Recent Development
Table 72. Roche Company Detail
Table 73. Roche Business Overview
Table 74. Roche Next Generation Sequencing (NGS) Product
Table 75. Roche Revenue in Next Generation Sequencing (NGS) Business (2018-2023) & (US$ Million)
Table 76. Roche Recent Development
Table 77. Agilent Technologies Company Detail
Table 78. Agilent Technologies Business Overview
Table 79. Agilent Technologies Next Generation Sequencing (NGS) Product
Table 80. Agilent Technologies Revenue in Next Generation Sequencing (NGS) Business (2018-2023) & (US$ Million)
Table 81. Agilent Technologies Recent Development
Table 82. Perkinelmer Company Detail
Table 83. Perkinelmer Business Overview
Table 84. Perkinelmer Next Generation Sequencing (NGS) Product
Table 85. Perkinelmer Revenue in Next Generation Sequencing (NGS) Business (2018-2023) & (US$ Million)
Table 86. Perkinelmer Recent Development
Table 87. Genomatix Company Detail
Table 88. Genomatix Business Overview
Table 89. Genomatix Next Generation Sequencing (NGS) Product
Table 90. Genomatix Revenue in Next Generation Sequencing (NGS) Business (2018-2023) & (US$ Million)
Table 91. Genomatix Recent Development
Table 92. PierianDx Company Detail
Table 93. PierianDx Business Overview
Table 94. PierianDx Next Generation Sequencing (NGS) Product
Table 95. PierianDx Revenue in Next Generation Sequencing (NGS) Business (2018-2023) & (US$ Million)
Table 96. PierianDx Recent Development
Table 97. Eurofins Scientific Company Detail
Table 98. Eurofins Scientific Business Overview
Table 99. Eurofins Scientific Next Generation Sequencing (NGS) Product
Table 100. Eurofins Scientific Revenue in Next Generation Sequencing (NGS) Business (2018-2023) & (US$ Million)
Table 101. Eurofins Scientific Recent Development
Table 102. Gatc Biotech Company Detail
Table 103. Gatc Biotech Business Overview
Table 104. Gatc Biotech Next Generation Sequencing (NGS) Product
Table 105. Gatc Biotech Revenue in Next Generation Sequencing (NGS) Business (2018-2023) & (US$ Million)
Table 106. Gatc Biotech Recent Development
Table 107. Oxford Nanopore Technologies Company Detail
Table 108. Oxford Nanopore Technologies Business Overview
Table 109. Oxford Nanopore Technologies Next Generation Sequencing (NGS) Product
Table 110. Oxford Nanopore Technologies Revenue in Next Generation Sequencing (NGS) Business (2018-2023) & (US$ Million)
Table 111. Oxford Nanopore Technologies Recent Development
Table 112. Bio-Rad Laboratories Company Detail
Table 113. Bio-Rad Laboratories Business Overview
Table 114. Bio-Rad Laboratories Next Generation Sequencing (NGS) Product
Table 115. Bio-Rad Laboratories Revenue in Next Generation Sequencing (NGS) Business (2018-2023) & (US$ Million)
Table 116. Bio-Rad Laboratories Recent Development
Table 117. DNASTAR Company Detail
Table 118. DNASTAR Business Overview
Table 119. DNASTAR Next Generation Sequencing (NGS) Product
Table 120. DNASTAR Revenue in Next Generation Sequencing (NGS) Business (2018-2023) & (US$ Million)
Table 121. DNASTAR Recent Development
Table 122. Biomatters Company Detail
Table 123. Biomatters Business Overview
Table 124. Biomatters Next Generation Sequencing (NGS) Product
Table 125. Biomatters Revenue in Next Generation Sequencing (NGS) Business (2018-2023) & (US$ Million)
Table 126. Biomatters Recent Development
Table 127. Partek Company Detail
Table 128. Partek Business Overview
Table 129. Partek Next Generation Sequencing (NGS) Product
Table 130. Partek Revenue in Next Generation Sequencing (NGS) Business (2018-2023) & (US$ Million)
Table 131. Partek Recent Development
Table 132. New England Biolabs Company Detail
Table 133. New England Biolabs Business Overview
Table 134. New England Biolabs Next Generation Sequencing (NGS) Product
Table 135. New England Biolabs Revenue in Next Generation Sequencing (NGS) Business (2018-2023) & (US$ Million)
Table 136. New England Biolabs Recent Development
Table 137. Myriad Genetics Company Detail
Table 138. Myriad Genetics Business Overview
Table 139. Myriad Genetics Next Generation Sequencing (NGS) Product
Table 140. Myriad Genetics Revenue in Next Generation Sequencing (NGS) Business (2018-2023) & (US$ Million)
Table 141. Myriad Genetics Recent Development
Table 142. Macrogen Company Detail
Table 143. Macrogen Business Overview
Table 144. Macrogen Next Generation Sequencing (NGS) Product
Table 145. Macrogen Revenue in Next Generation Sequencing (NGS) Business (2018-2023) & (US$ Million)
Table 146. Macrogen Recent Development
Table 147. Research Programs/Design for This Report
Table 148. Key Data Information from Secondary Sources
Table 149. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Next Generation Sequencing (NGS) Market Size Comparison by Type (2023-2033) & (US$ Million)
Figure 2. Global Next Generation Sequencing (NGS) Market Share by Type: 2022 VS 2033
Figure 3. Targeted Sequencing Features
Figure 4. Whole Exome Sequencing Features
Figure 5. Whole Genome Sequencing Features
Figure 6. Global Next Generation Sequencing (NGS) Market Size Comparison by Application (2023-2033) & (US$ Million)
Figure 7. Global Next Generation Sequencing (NGS) Market Share by Application: 2022 VS 2033
Figure 8. Academic & Government Research Institutes Case Studies
Figure 9. Pharmaceutical Companies Case Studies
Figure 10. Biotechnology Companies Case Studies
Figure 11. Hospitals & Clinics Case Studies
Figure 12. Next Generation Sequencing (NGS) Report Years Considered
Figure 13. Global Next Generation Sequencing (NGS) Market Size (US$ Million), Year-over-Year: 2018-2033
Figure 14. Global Next Generation Sequencing (NGS) Market Size, (US$ Million), 2018 VS 2022 VS 2033
Figure 15. Global Next Generation Sequencing (NGS) Market Share by Region: 2022 VS 2033
Figure 16. Global Next Generation Sequencing (NGS) Market Share by Players in 2022
Figure 17. Global Top Next Generation Sequencing (NGS) Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Next Generation Sequencing (NGS) as of 2022)
Figure 18. The Top 10 and 5 Players Market Share by Next Generation Sequencing (NGS) Revenue in 2022
Figure 19. North America Next Generation Sequencing (NGS) Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 20. North America Next Generation Sequencing (NGS) Market Share by Country (2018-2033)
Figure 21. United States Next Generation Sequencing (NGS) Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 22. Canada Next Generation Sequencing (NGS) Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 23. Europe Next Generation Sequencing (NGS) Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 24. Europe Next Generation Sequencing (NGS) Market Share by Country (2018-2033)
Figure 25. Germany Next Generation Sequencing (NGS) Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 26. France Next Generation Sequencing (NGS) Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 27. U.K. Next Generation Sequencing (NGS) Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 28. Italy Next Generation Sequencing (NGS) Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 29. Russia Next Generation Sequencing (NGS) Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 30. Nordic Countries Next Generation Sequencing (NGS) Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 31. Asia-Pacific Next Generation Sequencing (NGS) Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 32. Asia-Pacific Next Generation Sequencing (NGS) Market Share by Region (2018-2033)
Figure 33. China Next Generation Sequencing (NGS) Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 34. Japan Next Generation Sequencing (NGS) Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 35. South Korea Next Generation Sequencing (NGS) Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 36. Southeast Asia Next Generation Sequencing (NGS) Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 37. India Next Generation Sequencing (NGS) Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 38. Australia Next Generation Sequencing (NGS) Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 39. Latin America Next Generation Sequencing (NGS) Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 40. Latin America Next Generation Sequencing (NGS) Market Share by Country (2018-2033)
Figure 41. Mexico Next Generation Sequencing (NGS) Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 42. Brazil Next Generation Sequencing (NGS) Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 43. Middle East & Africa Next Generation Sequencing (NGS) Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 44. Middle East & Africa Next Generation Sequencing (NGS) Market Share by Country (2018-2033)
Figure 45. Turkey Next Generation Sequencing (NGS) Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 46. Saudi Arabia Next Generation Sequencing (NGS) Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 47. Illumina Revenue Growth Rate in Next Generation Sequencing (NGS) Business (2018-2023)
Figure 48. Thermo Fisher Scientific Revenue Growth Rate in Next Generation Sequencing (NGS) Business (2018-2023)
Figure 49. Pacific Biosciences of California Revenue Growth Rate in Next Generation Sequencing (NGS) Business (2018-2023)
Figure 50. Beijing Genomics Institute Revenue Growth Rate in Next Generation Sequencing (NGS) Business (2018-2023)
Figure 51. Qiagen Revenue Growth Rate in Next Generation Sequencing (NGS) Business (2018-2023)
Figure 52. Roche Revenue Growth Rate in Next Generation Sequencing (NGS) Business (2018-2023)
Figure 53. Agilent Technologies Revenue Growth Rate in Next Generation Sequencing (NGS) Business (2018-2023)
Figure 54. Perkinelmer Revenue Growth Rate in Next Generation Sequencing (NGS) Business (2018-2023)
Figure 55. Genomatix Revenue Growth Rate in Next Generation Sequencing (NGS) Business (2018-2023)
Figure 56. PierianDx Revenue Growth Rate in Next Generation Sequencing (NGS) Business (2018-2023)
Figure 57. Eurofins Scientific Revenue Growth Rate in Next Generation Sequencing (NGS) Business (2018-2023)
Figure 58. Gatc Biotech Revenue Growth Rate in Next Generation Sequencing (NGS) Business (2018-2023)
Figure 59. Oxford Nanopore Technologies Revenue Growth Rate in Next Generation Sequencing (NGS) Business (2018-2023)
Figure 60. Bio-Rad Laboratories Revenue Growth Rate in Next Generation Sequencing (NGS) Business (2018-2023)
Figure 61. DNASTAR Revenue Growth Rate in Next Generation Sequencing (NGS) Business (2018-2023)
Figure 62. Biomatters Revenue Growth Rate in Next Generation Sequencing (NGS) Business (2018-2023)
Figure 63. Partek Revenue Growth Rate in Next Generation Sequencing (NGS) Business (2018-2023)
Figure 64. New England Biolabs Revenue Growth Rate in Next Generation Sequencing (NGS) Business (2018-2023)
Figure 65. Myriad Genetics Revenue Growth Rate in Next Generation Sequencing (NGS) Business (2018-2023)
Figure 66. Macrogen Revenue Growth Rate in Next Generation Sequencing (NGS) Business (2018-2023)
Figure 67. Bottom-up and Top-down Approaches for This Report
Figure 68. Data Triangulation
Figure 69. Key Executives Interviewed